title: Important drug precaution for dental health professionals with patients being treated for cancer.
authors.affiliation: Novartis Oncology Medical Affairs and Services, East Hanover, NJ 07936, USA.
authors.forename: John A
authors.initials: JA
authors.lastname: Hohneker
authors.forename: Alan L
authors.initials: AL
authors.lastname: Bess
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D000075202:Contraindications; D003729:Dental Care; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced* / Q000517:prevention & control; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid